Increased PK11195 PET binding in the cortex of patients with MS correlates with disability
M Politis, P Giannetti, P Su, F Turkheimer… - Neurology, 2012 - AAN Enterprises
Objective: Activated microglia are thought to play a major role in cortical gray matter (GM)
demyelination in multiple sclerosis (MS). Our objective was to evaluate microglial activation in …
demyelination in multiple sclerosis (MS). Our objective was to evaluate microglial activation in …
[HTML][HTML] Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis
Background Depression, a condition commonly comorbid with multiple sclerosis (MS), is
associated more generally with elevated inflammatory markers and hippocampal pathology. …
associated more generally with elevated inflammatory markers and hippocampal pathology. …
Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
…, N Lahiri, F Niccolini, P Su, K Wu, P Giannetti… - Neurobiology of …, 2015 - Elsevier
Previous studies have shown activation of the immune system and altered immune response
in Huntington's disease (HD) gene carriers. Here, we hypothesized that peripheral and …
in Huntington's disease (HD) gene carriers. Here, we hypothesized that peripheral and …
In vivo assessment of brain white matter inflammation in multiple sclerosis with 18F-PBR111 PET
PET radioligand binding to the 18-kD translocator protein (TSPO) in the brains of patients
with multiple sclerosis (MS) primarily reflects activated microglia and macrophages. We …
with multiple sclerosis (MS) primarily reflects activated microglia and macrophages. We …
Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome
P Giannetti, M Politis, P Su, FE Turkheimer, O Malik… - Brain, 2015 - academic.oup.com
The most accurate predictor of the subsequent development of multiple sclerosis in clinically
isolated syndrome is the presence of lesions at magnetic resonance imaging. We used in …
isolated syndrome is the presence of lesions at magnetic resonance imaging. We used in …
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11) C](R)-PK11195-PET pilot study
P Giannetti, M Politis, P Su, F Turkheimer, O Malik… - Neurobiology of …, 2014 - Elsevier
The pathophysiological correlates and the contribution to persisting disability of hypointense
T1-weighted MRI lesions, black holes (BH), in multiple sclerosis (MS) are still unclear. In …
T1-weighted MRI lesions, black holes (BH), in multiple sclerosis (MS) are still unclear. In …
Development of oral immunomodulatory agents in the management of multiple sclerosis
R Nicholas, P Giannetti, A Alsanousi… - Drug Design …, 2011 - Taylor & Francis
The emergence of oral disease-modifying therapies in multiple sclerosis (MS) will have a
significant impact on the evolving scenario of immunomodulatory treatments in MS where …
significant impact on the evolving scenario of immunomodulatory treatments in MS where …
BG-12 and its potential for the prevention of relapse in multiple sclerosis
P Giannetti, F Niccolini, R Nicholas - … and Neuromuscular Disease, 2012 - Taylor & Francis
Multiple sclerosis (MS) arises from an immune attack on the central nervous system producing
demyelination and axonal loss. Clinically the relapsing–remitting course is characterized …
demyelination and axonal loss. Clinically the relapsing–remitting course is characterized …
Decreased microglial activation precedes stabilization of disability in multiple sclerosis patients treated with natalizumab (S21. 004)
OBJECTIVE: To investigate in vivo whether one-year treatment with natalizumab can influence
levels of activated microglia in brain areas which were found to be related to disability in …
levels of activated microglia in brain areas which were found to be related to disability in …
[HTML][HTML] Specific Btk inhibition suppresses B cell–and myeloid cell–mediated arthritis
…, L Diehl, R Ferrando, SL Gallion, AM Giannetti… - Nature chemical …, 2011 - nature.com
Bruton's tyrosine kinase (Btk) is a therapeutic target for rheumatoid arthritis, but the cellular
and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here …
and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here …